All In Biotech

Drug Trial Radar · NCT02528188

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY OF THE LONG-TERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

Last checked: Nov 19, 2026Latest source record: Jan 10, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 3,021 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,021

Actual

Start

Jul 21, 2015

Primary completion

Oct 5, 2018

Study completion Feb 27, 2019

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Aug 19, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the long-term joint safety and efficacy (pain relief) of the investigational study drug, tanezumab compared to non-steroidal anti inflammatory drugs (NSAIDs) in subjects with osteoarthritis of the hips or knees.

Conditions

  • Chronic Pain
  • Osteoarthritis, Hip
  • Osteoarthritis, Knee

Interventions

  • NSAIDDrug

    Orally administered NSAID (naproxen 500 mg, celecoxib 100 mg or diclofenac 75 mg) twice daily for 56 weeks

  • Tanezumab 2.5 mgBiological

    Subcutaneous injection of tanezumab 2.5 mg every 8 weeks for 56 weeks

  • Tanezumab 5 mgBiological

    Subcutaneous injection of tanezumab 5 mg every 8 weeks for 56 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Adjudicated Primary Composite Joint Safety OutcomeTime frame: Baseline up to Week 80
  2. Observation Time-Adjusted Event Rate of Participants With Adjudicated Primary Composite Joint Safety OutcomeTime frame: Baseline up to Week 80
  3. Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale at Week 16Time frame: Baseline, Week 16
  4. Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Physical Function Subscale at Week 16Time frame: Baseline, Week 16
  5. Change From Baseline in Patient's Global Assessment (PGA) of Osteoarthritis at Week 16Time frame: Baseline, Week 16

Locations

507 sites in 18 countries. Site status is shown where the registry gives one.

  • Central Alabama Research

    Birmingham, Alabama

  • Achieve Clinical Research, LLC

    Birmingham, Alabama

  • Alabama Clinical Therapeutics, LLC

    Birmingham, Alabama

  • Alabama Orthopaedic Surgeons

    Birmingham, Alabama

  • Rheumatology Associates of North Alabama, PC

    Huntsville, Alabama

  • Coastal Clinical Research, Inc.

    Mobile, Alabama

  • Ferguson Family Medicine

    Mesa, Arizona

  • Arizona Arthritis & Rheumatology Associates, P.C.

    Phoenix, Arizona

  • Arizona Research Center

    Phoenix, Arizona

  • Valley Pain Consultants

    Scottsdale, Arizona

  • Clinical Research Consortium

    Tempe, Arizona

  • Noble Clinical Research, LLC

    Tucson, Arizona

  • Quality of Life Medical & Research Centers, LLC

    Tucson, Arizona

  • Tucson Orthopaedic Institute - Research Center

    Tucson, Arizona

  • CHI St. Vincent Medical Group Hot Springs

    Hot Springs, Arkansas

  • Chrystal Johnson

    Little Rock, Arkansas

  • KLR Business Group, Inc., dba Arkansas Clinical Research

    Little Rock, Arkansas

  • Larry Watkins, MD

    Little Rock, Arkansas

  • Lynn Institute of the Ozarks

    Little Rock, Arkansas

  • Orange County Research Institute

    Anaheim, California

  • Advanced Research Center

    Anaheim, California

  • CITrials

    Bellflower, California

  • Osteoporosis Medical Center

    Beverly Hills, California

  • Hope Clinical Research

    Canoga Park, California

  • Med Center

    Carmichael, California

  • Core Healthcare Group

    Cerritos, California

  • Pleitez Medical Clinic

    Covina, California

  • Triwest Research Associates, LLC

    El Cajon, California

  • T. Joseph Raoof MD, INC/Encino Research Center

    Encino, California

  • San Diego Imaging Escondido

    Escondido, California

  • Med Investigations, Inc.

    Fair Oaks, California

  • Research Center of Fresno, Inc.

    Fresno, California

  • Neuro-Pain Medical Center

    Fresno, California

  • Collaborative Neuroscience Network, LLC.

    Garden Grove, California

  • Allied Clinical Research

    Gold River, California

  • HealthCare Partners Clinical Research, LLC.

    Huntington Beach, California

  • Marvel Clinical Research LLC

    Huntington Beach, California

  • BioSolutions Clinical Research Center

    La Mesa, California

  • eStudySite

    La Mesa, California

  • Arthritis & Osteoporosis Medical Center

    La Palma, California

Showing 40 of 507 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.